0001062993-22-010465.txt : 20220420
0001062993-22-010465.hdr.sgml : 20220420
20220420063703
ACCESSION NUMBER: 0001062993-22-010465
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220418
FILED AS OF DATE: 20220420
DATE AS OF CHANGE: 20220420
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ENLOE J DAVID JR
CENTRAL INDEX KEY: 0001201526
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36329
FILM NUMBER: 22836299
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Societal CDMO, Inc.
CENTRAL INDEX KEY: 0001588972
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261523233
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 E. UWCHLAN AVE, SUITE 112
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 770-534-8239
MAIL ADDRESS:
STREET 1: 1 E. UWCHLAN AVE, SUITE 112
CITY: EXTON
STATE: PA
ZIP: 19341
FORMER COMPANY:
FORMER CONFORMED NAME: Recro Pharma, Inc.
DATE OF NAME CHANGE: 20131010
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2022-04-18
0001588972
Societal CDMO, Inc.
SCTL
0001201526
ENLOE J DAVID JR
C/O SOCIETAL CDMO, INC.
1 E. UWCHLAN AVE, SUITE 112
EXTON
PA
19341
1
1
0
0
Chief Executive Officer
Common Stock
2022-04-18
4
P
0
625
1.63
A
502914
D
This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.
Ryan D Lake, attorney-in-fact
2022-04-20